US20060073597A1 - Highly controllable electroporation and applications thereof - Google Patents
Highly controllable electroporation and applications thereof Download PDFInfo
- Publication number
- US20060073597A1 US20060073597A1 US11/134,078 US13407805A US2006073597A1 US 20060073597 A1 US20060073597 A1 US 20060073597A1 US 13407805 A US13407805 A US 13407805A US 2006073597 A1 US2006073597 A1 US 2006073597A1
- Authority
- US
- United States
- Prior art keywords
- sub
- pore
- cell
- membrane
- energy sub
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/42—Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
Definitions
- the membrane of a cell serves the vital function of partitioning the molecular contents from its external environment.
- the membranes are largely composed of amphiphilic lipids, which self-assemble into highly insulating structures and thus present a large energy barrier to trans-membrane ionic transport.
- electroporation a well-known phenomenon known as electroporation.
- electroporation process involve permeation of cell membranes upon application of short duration electric field pulses, traditionally between relatively large plate electrodes (Neumann, et al., Bioelectrochem Bioenerg 48, 3-16 (1999); Ho, et al., Crit Rev Biotechnol 16, 349-62 (1996)).
- FIGS. 2A and 2B show a conventional electroporation system 20 , whereby impression of an electric field (e.g., shown by closing a circuit 22 ) creates random pores 26 in a cell membrane 24 .
- the distribution of such pores in terms of size and number only, is determined by the strength and duration of the applied electric field. The stronger and the longer the electric field is applied, the more numerous and larger the pores are. However, the exact location of such pores cannot be controlled, and thus the final distribution of pores is somewhat random.
- researchers lose control over where compounds are introduced into the intracellular matrix, an oft-important ingredient in biochemical pathways. Thus researchers often have to rely on the cell's own natural mechanisms, a far slower and difficult process to utilize.
- Electroporation is used for introducing macromolecules, including DNA, RNA, dyes, proteins and various chemical agents, into cells.
- macromolecules including DNA, RNA, dyes, proteins and various chemical agents.
- Large external electric fields induce high trans-membrane potentials leading to the formation of pores (e.g., having diameters in the range of 20-120 nm).
- charged macromolecules, including DNA are actively transported by electrophoresis across the cell membrane through these pores (Neumann, et al., Biophys J 712 868-77 (1996)). Uncharged molecules may also enter through the pores by passive diffusion.
- pores reseal over hundreds of milliseconds as measured by recovery of normal membrane conductance values (Ho, 1996, supra).
- This procedure is often used in laboratory settings to inject chemical and biological compounds into a cell, avoiding the reliance on the cell's own protein receptors and trans-membrane channels for transport across the cell membrane. This allows researchers to easily study the biological affect of compounds, be it a potentially life-saving cancer drug or a deadly biological toxin.
- current electroporation techniques are limited.
- the above-discussed and other problems and deficiencies of the prior art are overcome or alleviated by the several methods and apparatus of the present invention for controllable electroporation.
- the controllable electroporation system and method allows control over the size, the number, the location, and the distribution of aqueous pores, thus increasing flexibility of use.
- the herein described system and method for controllable electroporation generally employs at least two actuating sub-systems and sub-processes.
- One sub-system and sub-process employs a relatively broad effect in order to weaken the membrane, a broad effect sub-system.
- Another sub-system and sub-process employs a relatively narrow effect in order to localize the position of the pore in the membrane, a narrow effect sub-system.
- FIGS. 1A and 1B show operation of the controllable electroporation system described herein;
- FIGS. 2A and 2B show operation of conventional electroporation systems
- FIGS. 3A-3D show a general embodiment of a cell injection system
- FIG. 4A-4B shows an example of a cell injection system
- FIG. 5A-5B shows an example of a cell injection system for an array of cells
- FIG. 6 shows a separation device using multi-phospholipid layers and electroporation
- FIG. 7 shows a separation device using multiple layers, electroporation and a microfluid array
- FIG. 8 shows a separation device using a single layer capapble of having different pores at different locations
- FIG. 9 shows an exemplary electrode grid that may be used in various embodiments described herein.
- FIGS. 1A and 1B the herein described system 10 and method for controllable electroporation of a membrane 12 generally employs at least two actuating sub-systems and sub-processes.
- FIG. 1A shows a portion of a membrane 12
- FIG. 1B shows the controllable electroporation system 10 described herein.
- a broad effect sub-system 16 employs a relatively broad effect in order to weaken the membrane
- the narrow effect sub-system 18 employs a relatively narrow effect in order to localize the position of the pore 14 in the membrane 12 .
- Employing both the broad effect sub-system 16 and the narrow effect sub-system 18 enables highly localized and controlled electroporation and hence opening of pore 14 .
- the herein disclosed electroporation system and method employs a narrow effect sub-system 18 directed at a specific location on the cellular membrane, enabling positional control over the pore 14 .
- the narrow effect sub-system 18 will excite the phospholipid molecules, thus reducing the amount of energy required from the broad effect sub-system 16 to create the aqueous pores.
- a very weak electric field can be applied to a system, in which typically, electroporation would not occur.
- this weak electric field can open aqueous pores in places of the cellular membrane already excited by the laser beam.
- the broad effect sub-system or sub-process 16 may be selected from any suitable membrane weakening systems and/or processes. Such weakening systems and/or processes may be selected from the group consisting of electric fields (in certain preferred embodiments uniform electric fields), microwave energy, other electromagnetic radiation, relatively low energy laser beams (i.e., lower energy than that required to commence random electroporation), or any combination comprising at least one of the foregoing weakening systems and/or processes.
- the energy magnitude of the broad effect sub-system or process 16 is generally lower than the energy magnitude of conventional electroporation systems whereby random pore opening occur.
- the area (e.g., cross-sectional area) of the weakening systems and/or processes 16 generally encompasses an area larger than the desired pore size. In certain embodiments, this area encompasses the entire cell membrane or an array of cell membranes. In other embodiments, this area is a region of a membrane.
- the narrow effect sub-system or sub-process 18 may be selected from any suitable membrane pore position localization systems and/or processes. Such position localization systems and/or processes may be selected from the group consisting of laser beams, electrode tips, or any combination comprising at least one of the foregoing position localization systems and/or processes.
- the area (e.g., cross-sectional area) of the position localization systems and/or processes 18 is generally narrow, e.g., corresponding to the desired dimensions of the pore opening.
- controlled pore openings having of sub-micron or nanometer (e.g., 1-100 nm) magnitude are enabled, since existing and developing laser and electrode tip technologies are capable of such sub-micron-scale and nano-scale dimensions.
- controllable electroporation system and process may be used to inject macromolecules, including DNA, RNA, dyes, proteins and various chemical agents, in a controlled manner.
- FIGS. 3A-5B show various embodiments of cell pore opening systems employing the controllable electroporation system.
- FIG. 3A depicts the system 30 including a mechanism 32 for holding a cell 24 .
- Mechanism 32 is a suitable microrobotic device including associated Microsystems as are generally known in the biotechnology arts. Such as device 32 preferably is capable of holding individual cells or controlled groups of cells. Further, mechanism 32 may also be used to obtain biological, electrical, optical, or other data from the cell 24 .
- the system 30 is shown including the mechanism 32 holding the cell 24 , and a controllable electroporation system including the broad effect sub-system 16 and the narrow effect sub-system 18 , whereby the narrow effect sub-system 18 is focused at a location on the cell 24 to induce opening of a pore 34 .
- a macromolecule 38 is introduced, for example, via a nano-nozzle or other suitable injection device 36 .
- the narrow effect sub-system 18 and/or the broad effect sub-system 16 is removed, the pore will close, resulting in cell 24 ′ having macromolecule 38 therein.
- FIGS. 4A and 4B show one embodiment of a controllable electroporation system 40 for introducing controllably opening a pore 34 in a cell 24 , e.g., for introduction of macromolecules as described above.
- the system 40 includes a broad effect sub-system in the form of an electric field producing apparatus 42 , 44 , 46 , and a laser beam 48 from a suitable source (not shown).
- the electric field producing apparatus is in the form of an electrode plate 42 coupled to a switchable (via a switch 44 ) voltage source 46 .
- the laser beam may be focused, and the electric field applied to active the pore opening mechanism, akin to a logical “and” circuit as described above.
- FIGS. 5A and 5B a system 50 is shown that operates similar to that of FIGS. 3A-3D or 4 A- 4 B in conjunction with an array 52 of cells 24 .
- pores 34 are formed in the cells 24 . Such pores may be used for selective introduction of macromolecules into the cells 24 .
- FIGS. 6-10 various embodiments of filtration/separation devices are provided using the controllable electroporation system herein.
- FIG. 6 depicted one embodiment of a system 60 , e.g., a molecular sieve.
- System 60 includes plural membrane layers 62 , e.g., phospholipid bilayers.
- Each membrane layer 62 may be subject to a narrow effect sub-system during application of the broad effect sub-system, alternatively the location of the pores 64 may be predetermined upon assembly and or manufacture, e.g., with suitable micro- or nano-defects, or may be identical whereby different voltage levels at each layer determined the pore size.
- Application of different voltages e.g. V 1 , V 2 and V 3 ) at each layer creates a filter gradient from large pores 64 to small pores 64 , allowing passage of molecules 66 through suitable layers.
- the same filter 60 can be used repeatedly and adapted for any size requirements using electroporation and carefully controlling the electric field that is applied. Instead of depending on multiple filters, a single filter could be used and configured for any situation.
- a system 70 is shown with a molecular sieve functioning similar to that of FIG. 6 associated with a biochip array 72 having channels 74 therein.
- Channels 74 may serve to collect macromolecules and molecules at each level based on size.
- channels 74 may incorporate or be associated with a gradient system, e.g., pressure, thermal, electrical, or other gradient to induce macromolecules and molecules toward the array 72 .
- Array 72 may be any suitable microfluidic or nanofluidic device. For example, methods of manufacturing such devices are described in Reveo Inc. PCT Application No. PCT/US03/37304 filed Nov. 30, 2003 entitled “Three Dimensional Device Assembly and Production Methods Thereof”, which is incorporated by reference herein.
- FIG. 8 shows another example dynamic filtration device, wherein an array of lasers provides positional control over the pore openings.
- FIG. 80 shows a filtration system 80 including a membrane layer 82 associated with a broad effect energy sub-system 16 and a narrow effect sub-system 18 .
- the narrow effect sub-system 18 may be generated with a laser array 88 .
- a beam steering device may be incorporated, allowing use of only one laser source.
- a laser is activated from the array associated with a certain position on the membrane 82 , a pore 84 will open.
- the size of the pores may be controlled by predetermined membrane characteristics, area or magnitude of the narrow effect energy sub-system, or magnitude of the broad effect energy sub-system.
- Cells, proteins, enzymes, DNA molecules, RNA molecules, and other macromolecules or molecules may be collected via an array of containers 86 , e.g., on a suitable microfluidic device.
- separation device 80 may be made extremely compact and highly flexible for any purpose.
- FIG. 9 shows an example of an electrode suitable for providing the broad effect energy sub-system in various embodiments shown herein.
- a suitable field generating system may be provided to allow access for various purposes including the narrow effect sub-system, macromolecule introduction, filtration, or any other purpose.
- the aforementioned separation devices may also separate on the basis of ionic charge, since the applied voltage will drive only one type of ions across the membrane.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Electromagnetism (AREA)
- Medicinal Chemistry (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
The controllable electroporation system and method described herein allows control over the size, the number, the location, and the distribution of aqueous pores, thus increasing flexibility of use. The herein described system and method for controllable electroporation generally employs at least two actuating sub-systems and sub-processes. One sub-system and sub-process employs a relatively broad effect in order to weaken the membrane, a broad effect sub-system. Another sub-system and sub-process employs a relatively narrow effect in order to localize the position of the pore in the membrane, a narrow effect sub-system.
Description
- This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 60/439,387 filed on Jan. 10, 2003, which is herein incorporated by reference
- The membrane of a cell serves the vital function of partitioning the molecular contents from its external environment. The membranes are largely composed of amphiphilic lipids, which self-assemble into highly insulating structures and thus present a large energy barrier to trans-membrane ionic transport.
- However, the lipid matrix can be disrupted by a strong external electric field leading to an increase in trans-membrane conductivity and diffusive permeability, a well-known phenomenon known as electroporation. These effects are the result of formation of aqueous pores in the membrane. More particularly, electroporation process involve permeation of cell membranes upon application of short duration electric field pulses, traditionally between relatively large plate electrodes (Neumann, et al., Bioelectrochem Bioenerg 48, 3-16 (1999); Ho, et al., Crit Rev Biotechnol 16, 349-62 (1996)).
- For example,
FIGS. 2A and 2B show aconventional electroporation system 20, whereby impression of an electric field (e.g., shown by closing a circuit 22) createsrandom pores 26 in acell membrane 24. The distribution of such pores, in terms of size and number only, is determined by the strength and duration of the applied electric field. The stronger and the longer the electric field is applied, the more numerous and larger the pores are. However, the exact location of such pores cannot be controlled, and thus the final distribution of pores is somewhat random. Researchers lose control over where compounds are introduced into the intracellular matrix, an oft-important ingredient in biochemical pathways. Thus researchers often have to rely on the cell's own natural mechanisms, a far slower and difficult process to utilize. - Electroporation is used for introducing macromolecules, including DNA, RNA, dyes, proteins and various chemical agents, into cells. Large external electric fields induce high trans-membrane potentials leading to the formation of pores (e.g., having diameters in the range of 20-120 nm). During the application of the electric pulse, charged macromolecules, including DNA, are actively transported by electrophoresis across the cell membrane through these pores (Neumann, et al., Biophys J 712 868-77 (1996)). Uncharged molecules may also enter through the pores by passive diffusion. Upon pulse termination, pores reseal over hundreds of milliseconds as measured by recovery of normal membrane conductance values (Ho, 1996, supra).
- This procedure is often used in laboratory settings to inject chemical and biological compounds into a cell, avoiding the reliance on the cell's own protein receptors and trans-membrane channels for transport across the cell membrane. This allows researchers to easily study the biological affect of compounds, be it a potentially life-saving cancer drug or a deadly biological toxin. However, current electroporation techniques are limited.
- Therefore, it would be desirable to provide a method and system to overcome these and other limitations of conventional electroporation.
- The above-discussed and other problems and deficiencies of the prior art are overcome or alleviated by the several methods and apparatus of the present invention for controllable electroporation. The controllable electroporation system and method allows control over the size, the number, the location, and the distribution of aqueous pores, thus increasing flexibility of use. The herein described system and method for controllable electroporation generally employs at least two actuating sub-systems and sub-processes. One sub-system and sub-process employs a relatively broad effect in order to weaken the membrane, a broad effect sub-system. Another sub-system and sub-process employs a relatively narrow effect in order to localize the position of the pore in the membrane, a narrow effect sub-system.
- The above-discussed and other features and advantages of the present invention will be appreciated and understood by those skilled in the art from the following detailed description and drawings.
-
FIGS. 1A and 1B show operation of the controllable electroporation system described herein; -
FIGS. 2A and 2B show operation of conventional electroporation systems; -
FIGS. 3A-3D show a general embodiment of a cell injection system; -
FIG. 4A-4B shows an example of a cell injection system; -
FIG. 5A-5B shows an example of a cell injection system for an array of cells; -
FIG. 6 shows a separation device using multi-phospholipid layers and electroporation; -
FIG. 7 shows a separation device using multiple layers, electroporation and a microfluid array; -
FIG. 8 shows a separation device using a single layer capapble of having different pores at different locations; and -
FIG. 9 shows an exemplary electrode grid that may be used in various embodiments described herein. - Herein described is an electroporation system and method providing control over the size, the number, the location, and the distribution of aqueous pores, thus increasing flexibility of use. Referring generally to
FIGS. 1A and 1B , the herein describedsystem 10 and method for controllable electroporation of amembrane 12 generally employs at least two actuating sub-systems and sub-processes.FIG. 1A shows a portion of amembrane 12, andFIG. 1B shows thecontrollable electroporation system 10 described herein. - Note that in general, one of the actuating sub-systems alone will not suffice to open or create a
pore 14 in the membrane—both actuating sub-systems are employed, thereby functioning in a similar manner as a logical “and” gate. Abroad effect sub-system 16 employs a relatively broad effect in order to weaken the membrane, and thenarrow effect sub-system 18 employs a relatively narrow effect in order to localize the position of thepore 14 in themembrane 12. Employing both thebroad effect sub-system 16 and thenarrow effect sub-system 18 enables highly localized and controlled electroporation and hence opening ofpore 14. - Therefore, for example as compared to conventional electroporation processes of cellular membranes, described in the Background and with respect to
FIGS. 2A and 2B , in addition to the applied electric field of conventional electroporation technology, the herein disclosed electroporation system and method employs anarrow effect sub-system 18 directed at a specific location on the cellular membrane, enabling positional control over thepore 14. Thenarrow effect sub-system 18 will excite the phospholipid molecules, thus reducing the amount of energy required from thebroad effect sub-system 16 to create the aqueous pores. Thus, for example, a very weak electric field can be applied to a system, in which typically, electroporation would not occur. However, this weak electric field can open aqueous pores in places of the cellular membrane already excited by the laser beam. - The broad effect sub-system or
sub-process 16 may be selected from any suitable membrane weakening systems and/or processes. Such weakening systems and/or processes may be selected from the group consisting of electric fields (in certain preferred embodiments uniform electric fields), microwave energy, other electromagnetic radiation, relatively low energy laser beams (i.e., lower energy than that required to commence random electroporation), or any combination comprising at least one of the foregoing weakening systems and/or processes. The energy magnitude of the broad effect sub-system orprocess 16 is generally lower than the energy magnitude of conventional electroporation systems whereby random pore opening occur. Further, the area (e.g., cross-sectional area) of the weakening systems and/orprocesses 16 generally encompasses an area larger than the desired pore size. In certain embodiments, this area encompasses the entire cell membrane or an array of cell membranes. In other embodiments, this area is a region of a membrane. - The narrow effect sub-system or sub-process 18 may be selected from any suitable membrane pore position localization systems and/or processes. Such position localization systems and/or processes may be selected from the group consisting of laser beams, electrode tips, or any combination comprising at least one of the foregoing position localization systems and/or processes. The area (e.g., cross-sectional area) of the position localization systems and/or processes 18 is generally narrow, e.g., corresponding to the desired dimensions of the pore opening. Thus, for example, controlled pore openings having of sub-micron or nanometer (e.g., 1-100 nm) magnitude are enabled, since existing and developing laser and electrode tip technologies are capable of such sub-micron-scale and nano-scale dimensions.
- Applications
- Cell Injection
- The herein described controllable electroporation system and process may be used to inject macromolecules, including DNA, RNA, dyes, proteins and various chemical agents, in a controlled manner. Without intending to limit the applications of the present controllable electroporation system,
FIGS. 3A-5B show various embodiments of cell pore opening systems employing the controllable electroporation system. - Referring now to
FIGS. 3A-3D , asystem 30 is shown for controllable injecting macromolecules into a cell.FIG. 3A depicts thesystem 30 including amechanism 32 for holding acell 24.Mechanism 32 is a suitable microrobotic device including associated Microsystems as are generally known in the biotechnology arts. Such asdevice 32 preferably is capable of holding individual cells or controlled groups of cells. Further,mechanism 32 may also be used to obtain biological, electrical, optical, or other data from thecell 24. - Referring now to
FIG. 3B , thesystem 30 is shown including themechanism 32 holding thecell 24, and a controllable electroporation system including thebroad effect sub-system 16 and thenarrow effect sub-system 18, whereby thenarrow effect sub-system 18 is focused at a location on thecell 24 to induce opening of apore 34. - Referring now to
FIG. 3C , amacromolecule 38 is introduced, for example, via a nano-nozzle or othersuitable injection device 36. When thenarrow effect sub-system 18 and/or thebroad effect sub-system 16 is removed, the pore will close, resulting incell 24′ havingmacromolecule 38 therein. -
FIGS. 4A and 4B show one embodiment of acontrollable electroporation system 40 for introducing controllably opening apore 34 in acell 24, e.g., for introduction of macromolecules as described above. Thesystem 40 includes a broad effect sub-system in the form of an electricfield producing apparatus laser beam 48 from a suitable source (not shown). The electric field producing apparatus is in the form of anelectrode plate 42 coupled to a switchable (via a switch 44)voltage source 46. As shown, the laser beam may be focused, and the electric field applied to active the pore opening mechanism, akin to a logical “and” circuit as described above. - With the system and method described with respect to
FIGS. 3A-3D and 4A-4B, researchers could only expose a few cells in a tissue construct to a biological compound and observe how the signal is propagated to its neighboring cells. Alternatively, researchers could study if asymmetric cells such as neurons and gastrointestinal mucosa cells react differently to compounds injected at different places. - Referring now to
FIGS. 5A and 5B , asystem 50 is shown that operates similar to that ofFIGS. 3A-3D or 4A-4B in conjunction with anarray 52 ofcells 24. When thebroad effect sub-system 16 and thenarrow effect sub-system 18 are operated, pores 34 are formed in thecells 24. Such pores may be used for selective introduction of macromolecules into thecells 24. - Separation Device Referring now to
FIGS. 6-10 , various embodiments of filtration/separation devices are provided using the controllable electroporation system herein. -
FIG. 6 depicted one embodiment of asystem 60, e.g., a molecular sieve.System 60 includes plural membrane layers 62, e.g., phospholipid bilayers. Eachmembrane layer 62 may be subject to a narrow effect sub-system during application of the broad effect sub-system, alternatively the location of thepores 64 may be predetermined upon assembly and or manufacture, e.g., with suitable micro- or nano-defects, or may be identical whereby different voltage levels at each layer determined the pore size. Application of different voltages (e.g. V1, V2 and V3) at each layer creates a filter gradient fromlarge pores 64 tosmall pores 64, allowing passage ofmolecules 66 through suitable layers. - Using a phospholipid bilayer, which is extremely cheap to manufacture, the
same filter 60 can be used repeatedly and adapted for any size requirements using electroporation and carefully controlling the electric field that is applied. Instead of depending on multiple filters, a single filter could be used and configured for any situation. - Referring to
FIG. 7 , asystem 70 is shown with a molecular sieve functioning similar to that ofFIG. 6 associated with abiochip array 72 havingchannels 74 therein.Channels 74 may serve to collect macromolecules and molecules at each level based on size. Further,channels 74 may incorporate or be associated with a gradient system, e.g., pressure, thermal, electrical, or other gradient to induce macromolecules and molecules toward thearray 72.Array 72 may be any suitable microfluidic or nanofluidic device. For example, methods of manufacturing such devices are described in Reveo Inc. PCT Application No. PCT/US03/37304 filed Nov. 30, 2003 entitled “Three Dimensional Device Assembly and Production Methods Thereof”, which is incorporated by reference herein. -
FIG. 8 shows another example dynamic filtration device, wherein an array of lasers provides positional control over the pore openings.FIG. 80 shows afiltration system 80 including amembrane layer 82 associated with a broadeffect energy sub-system 16 and anarrow effect sub-system 18. For example, thenarrow effect sub-system 18 may be generated with alaser array 88. Alternatively, instead of an array oflasers 88, a beam steering device may be incorporated, allowing use of only one laser source. When a laser is activated from the array associated with a certain position on themembrane 82, apore 84 will open. The size of the pores may be controlled by predetermined membrane characteristics, area or magnitude of the narrow effect energy sub-system, or magnitude of the broad effect energy sub-system. - Cells, proteins, enzymes, DNA molecules, RNA molecules, and other macromolecules or molecules may be collected via an array of
containers 86, e.g., on a suitable microfluidic device. Thus,separation device 80 may be made extremely compact and highly flexible for any purpose. -
FIG. 9 shows an example of an electrode suitable for providing the broad effect energy sub-system in various embodiments shown herein. By providing electrodes in a grid pattern, a suitable field generating system may be provided to allow access for various purposes including the narrow effect sub-system, macromolecule introduction, filtration, or any other purpose. - In addition to filtering based on size, the aforementioned separation devices may also separate on the basis of ionic charge, since the applied voltage will drive only one type of ions across the membrane.
- While preferred embodiments have been shown and described, various modifications and substitutions may be made thereto without departing from the spirit and scope of the invention. Accordingly, it is to be understood that the present invention has been described by way of illustrations and not limitation.
Claims (26)
1. A system for controllable electroporation of a membrane comprising:
a broad energy sub-system operably coupled to the membrane and
a narrow energy sub-system operably coupled to the membrane,
wherein a pore is opened or created at a position corresponding to the position of the narrow energy.
2. The system as in claim 1 , wherein the broad energy sub-system is selected from the group of weakening systems consisting of electric fields, microwave energy, other electromagnetic radiation, low energy laser beams, or any combination comprising at least one of the foregoing weakening systems.
3. The system as in claim 1 , wherein the energy magnitude of the broad energy sub-system is lower than the energy magnitude of electroporation systems without the narrow effect sub-system whereby random pore opening occur.
4. The system as in claim 1 , wherein the area of the broad energy sub-system encompasses an area larger than the desired pore size.
5. The system as in claim 1 , wherein the area of the broad energy sub-system encompasses the membrane of a cell.
6. The system as in claim 1 , wherein the area of the broad energy sub-system encompasses membranes of an array of cells.
7. The system as in claim 1 , wherein the area of the broad energy sub-system encompasses a region of a membrane.
8. The system as in claim 1 , wherein the narrow energy sub-system is selected from the group of position localization systems consisting of laser beams, electrode tips, or any combination comprising at least one of the foregoing position localization systems.
9. The system as in claim 1 , wherein the area of the narrow energy sub-system corresponds to the dimensions of the pore opening.
10. The system as in claim 1 , wherein the pore has sub-micron dimensions.
11. The system as in claim 1 , wherein the pore has dimensions of about 100 nanometers or less.
12. A controllable electroporation system comprising:
a broad energy sub-system operably coupled for providing broad energy to the membrane and
a narrow energy sub-system operably coupled to the membrane,
wherein a pore is opened when both the broad energy sub-system and the narrow energy sub-system are activated.
13-23. (canceled)
24. A cell pore opening system comprising:
a microrobotic device for holding a cell and
a system as in claim 1 for controllably opening a pore in the cell.
25. The cell pore opening system as in claim 24 , wherein the broad energy sub-system comprises an electrode plate and a switchable voltage source.
26. The cell pore opening system as in claim 24 , wherein the narrow energy sub-system comprises a laser.
27. A cell pore macromolecule system comprising:
a microrobotic device for holding a cell;
a system as in claim 1 for controllably opening a pore in the cell; and
a macromolecule injection device for injecting a macromolecule into the cell via the pore.
28-29. (canceled)
30. A system for filtering molecules or macromolecules comprising:
a plurality of membrane layers, each membrane layer including a system as in claim 1 for controllably opening a pore in the cell, each membrane layer opened to a different size to create a pore size gradient.
31. A system for filtering molecules or macromolecules comprising:
a plurality of membrane layers,
a broad energy sub-system associated with each membrane layer,
wherein each layer includes a position having a defect whereby said position is closed without activation of the broad energy sub-system and said position is opened upon activation of the broad energy sub-system.
32. The system as in claim 31 , wherein said defect at each layer controls the size of the pore.
33. The system as in claim 31 , wherein the magnitude of the energy of the broad energy sub-system controls the size of the pore.
34. A system for filtering molecules or macromolecules comprising:
a membrane layer including a system as in claim 1 for controllably opening a pore in the cell,
wherein the narrow energy sub-system comprises an array of narrow energy sub-sub-systems.
35. A system for filtering molecules or macromolecules comprising:
a membrane layer including a system as in claim 1 for controllably opening a pore in the cell,
wherein the narrow energy sub-system comprises an array of lasers.
36. A system for filtering molecules or macromolecules comprising:
a membrane layer including a system as in claim 1 for controllably opening a pore in the cell,
wherein the narrow energy sub-system comprises a beam steering device associated with a source of electromagnetic energy.
37-47. (canceled)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/134,078 US20060073597A1 (en) | 2003-01-10 | 2005-05-20 | Highly controllable electroporation and applications thereof |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43938703P | 2003-01-10 | 2003-01-10 | |
US10/755,709 US6962816B2 (en) | 2003-01-10 | 2004-01-12 | Highly controllable electroporation and applications thereof |
US11/134,078 US20060073597A1 (en) | 2003-01-10 | 2005-05-20 | Highly controllable electroporation and applications thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/755,709 Continuation US6962816B2 (en) | 2003-01-10 | 2004-01-12 | Highly controllable electroporation and applications thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060073597A1 true US20060073597A1 (en) | 2006-04-06 |
Family
ID=32713474
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/755,709 Expired - Fee Related US6962816B2 (en) | 2003-01-10 | 2004-01-12 | Highly controllable electroporation and applications thereof |
US11/134,078 Abandoned US20060073597A1 (en) | 2003-01-10 | 2005-05-20 | Highly controllable electroporation and applications thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/755,709 Expired - Fee Related US6962816B2 (en) | 2003-01-10 | 2004-01-12 | Highly controllable electroporation and applications thereof |
Country Status (7)
Country | Link |
---|---|
US (2) | US6962816B2 (en) |
EP (1) | EP1615988A2 (en) |
JP (1) | JP2006515758A (en) |
KR (1) | KR20050095607A (en) |
CN (1) | CN1759172A (en) |
TW (1) | TW200413525A (en) |
WO (1) | WO2004063350A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100322911A1 (en) * | 2009-02-25 | 2010-12-23 | Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center | Use of microwave irradiation for delivery of macromolecules |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004063350A2 (en) * | 2003-01-10 | 2004-07-29 | Reveo, Inc. | Highly controllable electroporation and applications thereof |
EP1941537A4 (en) * | 2005-10-20 | 2010-03-31 | Univ Ohio State | Drug and gene delivery by polymer nanonozzle and nanotip cell patch |
JP2008136400A (en) * | 2006-11-30 | 2008-06-19 | Olympus Corp | Gene transfer device and method therefor |
US20080138876A1 (en) * | 2006-12-11 | 2008-06-12 | Bio-Rad Laboratories, Inc. | Transfection in electronically driven continuous flow |
AU2012255988B2 (en) * | 2011-05-13 | 2017-07-13 | The Regents Of The University Of California | Photothermal substrates for selective transfection of cells |
CA2905999A1 (en) | 2013-03-15 | 2014-09-25 | The Regents Of The University Of California | High-throughput cargo delivery into live cells using photothermal platforms |
AU2015235932B2 (en) | 2014-03-28 | 2021-08-05 | The Regents Of The University Of California | Efficient delivery of large cargos into cells on a porous substrate |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6962816B2 (en) * | 2003-01-10 | 2005-11-08 | Reveo, Inc. | Highly controllable electroporation and applications thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6312612B1 (en) * | 1999-06-09 | 2001-11-06 | The Procter & Gamble Company | Apparatus and method for manufacturing an intracutaneous microneedle array |
US6565532B1 (en) * | 2000-07-12 | 2003-05-20 | The Procter & Gamble Company | Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup |
-
2004
- 2004-01-12 WO PCT/US2004/000632 patent/WO2004063350A2/en not_active Application Discontinuation
- 2004-01-12 EP EP04701501A patent/EP1615988A2/en not_active Withdrawn
- 2004-01-12 KR KR1020057012871A patent/KR20050095607A/en not_active Application Discontinuation
- 2004-01-12 US US10/755,709 patent/US6962816B2/en not_active Expired - Fee Related
- 2004-01-12 JP JP2006500899A patent/JP2006515758A/en not_active Withdrawn
- 2004-01-12 TW TW093100735A patent/TW200413525A/en unknown
- 2004-01-12 CN CNA2004800064328A patent/CN1759172A/en active Pending
-
2005
- 2005-05-20 US US11/134,078 patent/US20060073597A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6962816B2 (en) * | 2003-01-10 | 2005-11-08 | Reveo, Inc. | Highly controllable electroporation and applications thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100322911A1 (en) * | 2009-02-25 | 2010-12-23 | Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center | Use of microwave irradiation for delivery of macromolecules |
US8569251B2 (en) | 2009-02-25 | 2013-10-29 | The Charlotte-Mecklenburg Hospital Authority | Use of microwave irradiation for delivery of macromolecules |
Also Published As
Publication number | Publication date |
---|---|
CN1759172A (en) | 2006-04-12 |
JP2006515758A (en) | 2006-06-08 |
KR20050095607A (en) | 2005-09-29 |
US20040241859A1 (en) | 2004-12-02 |
WO2004063350A3 (en) | 2005-04-14 |
WO2004063350A2 (en) | 2004-07-29 |
US6962816B2 (en) | 2005-11-08 |
EP1615988A2 (en) | 2006-01-18 |
TW200413525A (en) | 2004-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060073597A1 (en) | Highly controllable electroporation and applications thereof | |
Dey et al. | A reversibly gated protein-transporting membrane channel made of DNA | |
Perrier et al. | Lipid vesicles in pulsed electric fields: fundamental principles of the membrane response and its biomedical applications | |
Wang et al. | Single-cell electroporation | |
WO1999031503A1 (en) | Positioning and electrophysiological characterization of individual cells and reconstituted membrane systems on microstructured carriers | |
Shen et al. | Advanced DNA nanopore technologies | |
Baek et al. | Ion gating in nanopore electrode arrays with hierarchically organized pH-responsive block copolymer membranes | |
US20140353172A1 (en) | Devices and methods for long-term intracellular access | |
US7001501B2 (en) | Method for etching at least one ion track to a pore in a membrane and electrolyte cell for preparing the membrane | |
Tien et al. | The bilayer lipid membrane (BLM) under electrical fields | |
Thomas et al. | Programming membrane permeability using integrated membrane pores and blockers as molecular regulators | |
Ramos et al. | Electrofusion: a biophysical modification of cell membrane and a mechanism in exocytosis | |
US9880122B2 (en) | Method for enhancing current throughput in an electrochemical system | |
US20140113356A1 (en) | Nano-electrode based chip | |
US20030062657A1 (en) | On-chip membrane maker | |
EP2751565A2 (en) | Carrier material for electrically polarisable biomaterials, polyelectrolyte materials, atoms, ions and molecules; production and use thereof | |
DE102005030858A1 (en) | Electrode assembly, its use and method for their preparation | |
Thutupalli | Towards autonomous soft matter systems: experiments on membranes and active emulsions | |
KR101830758B1 (en) | Sample separation device | |
Aten et al. | Testing of a pumpless MEMS microinjection needle employing electrostatic attraction and repulsion of DNA | |
DE10244129B4 (en) | H + -K + -ATPase assay | |
Coster | Self-assembly, stability and the electrical characteristics of cell membranes | |
Kupfer | A chip-based system for highly parallel and capacitive stimulation of electroporation | |
JP2006153733A (en) | Immobilization method for liposome, liposome microarray chip, and manufacturing method therefor | |
Ichino et al. | Clogging Probability of Nicked DNA Molecules on Solid-State Nanopores |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |